| 1 |
Jain A. Long-term survival after liver transplantation in 4 000 consecutive patients at a single center[J]. Ann Surg, 2000, 232(4): 490-500.
|
| 2 |
中国医师协会器官移植医师分会，中华医学会器官移植学分会肝移植学组. 中国肝移植受者肾损伤管理专家共识(2017版)[J/CD]. 中华移植杂志：电子版，2017, 11(3): 130-137.
|
| 3 |
Angeli P, Bezinover D, Biancofiore G, et al. Acute kidney injury in liver transplant candidates: a position paper on behalf of the Liver Intensive Care Group of Europe[J]. Minerva Anestesiol, 2017, 83(1): 88-101.
|
| 4 |
Rubin A, Sanchez-Montes C, Aguilera V, et al. Long-term outcome of ′long-term liver transplant survivors′[J]. Transpl Int, 2013, 26(7):740-750.
|
| 5 |
Levitsky J, O′Leary JG, Asrani S, et al. Protecting the kidney in liver transplant recipients：practice-based recommendations from the American society of Transplantation Liver and Intestine Community of Practice[J]. Am J Transplant, 2016, 16(9): 2532-2544.
|
| 6 |
Francoz C, Nadim MK, Baron A, et al. Glomerular filtration rate equations for liver-kidney transplantation in patients with cirrhosis: validation of current recommendations[J]. Hepatology, 2014, 59(4): 1514-1521
|
| 7 |
Ostermann M, Joannidis M. Acute kidney injury 2016: diagnosis and diagnostic workup[J]. Crit Care, 2016, 20(1): 299.
|
| 8 |
Improving Global Outcomes (KDIGO) Acute Kidney Injury Work Group. KDIGO clinical practice guideline for acute kidney injury[J]. Kidney Int Suppl, 2012, 2(Suppl 1): S1-S138.
|
| 9 |
Cullaro G, Park M, Lai J. ″Normal″ creatinine levels predict persistent kidney injury and waitlist mortality in outpatients with cirrhosis[J]. Hepatology, 2018, 68(5): 1953-1960.
|
| 10 |
Vagefi PA, Qian JJ, Carlson DM, et al. Native renal function after combined liver-kidney transplant for type 1 hepatorenal syndrome: initial report on the use of postoperative Technetium-99m-mercaptoacetyltriglycine scans[J]. Transplant Int, 2013, 26(5): 471-476.
|
| 11 |
Leithead JA, Ferguson JW. Chronic kidney disease after liver transplantation[J]. J Hepatol, 2015, 62(1): 243-244.
|
| 12 |
Inker LA, Schmid CH, Tighiouart H, et al. Estimating glomerular filtration rate from serum creatinine and cystatin C[J]. N Engl J Med, 2012, 367(1): 20-29.
|
| 13 |
Levey AS, Stevens LA, Schmid CH, et al. A new equation to estimate glomerular filtrationrate[J]. Ann Intern Med, 2009, 150(9): 604-612.
|
| 14 |
Gowrishankar M, VanderPluym C, Robert C, et al. Value of serum cystatin C in estimating renal function in children with non-renal solid organ transplantation[J]. Pediatr Transplant, 2015, 19(1): 27-34.
|
| 15 |
Singal AK, Jackson B, Pereira GB, et al. Biomarkers of Renal Injury in cirrhosis: association with acute kidney injury and recovery after liver transplantation[J]. Nephron, 2018, 138(1): 1-12.
|
| 16 |
Wadei HM, Geiger XJ, Cortese C, et al. Kidney allocation to liver transplant candidates with renal failure of undetermined etiology: role of percutaneous renal biopsy[J]. Am J Transplant, 2008, 8(12): 2618-2626.
|
| 17 |
Fagundes C, Pepin MN, Guevara M, et al. Urinary neutrophil gelatinase-associated lipocalin as biomarker in the differential diagnosis of impairment of kidney function in cirrhosis[J]. J Hepatol, 2012, 57(2): 267-273.
|
| 18 |
Barreto R, Elia C, Sola E, et al. Urinary neutrophil gelatinase-associated lipocalin predicts kidney outcome and death in patients with cirrhosis and bacterial infections[J]. J Hepatol, 2014, 61(1): 35-42.
|
| 19 |
Belcher JM, Garcia-Tsao G, Sanyal AJ, et al. Urinary biomarkers and progression of AKI in patients with cirrhosis[J]. Clin J Am Soc Nephrol, 2014, 9(11): 1857-1867.
|
| 20 |
Verna EC, Brown RS, Farrand E, et al. Urinaryneutrophil gelatinase-associated lipocalin predicts mortality and identifies acute kidney injury in cirrhosis[J]. Dig Dis Sci, 2012, 57(9): 2362-2370.
|
| 21 |
Belcher JM, Sanyal AJ, Peixoto AJ, et al. Kidney biomarkers and differential diagnosis of patients with cirrhosis and acute kidney injury[J]. Hepatology, 2014, 60(2): 622-632.
|
| 22 |
Ariza X, Sola E, Elia C, et al. Analysis of a urinary biomarker panel for clinical outcomes assessment in cirrhosis[J]. PLoS One, 2015, 10(6): e0128145.
|
| 23 |
Wagener G, Minhaz M, Mattis FA, et al. Urinary neutrophil gelatinase-associated lipocalin as a marker of acute kidney injury after orthotopic liver transplantation[J]. Nephrol Dial Transplant, 2011, 26(5): 1717-1723.
|
| 24 |
Levitsky J, Baker TB, Jie C, et al. Plasma protein biomarkers enhance the clinical prediction of kidney injury recovery in patients undergoing liver transplantation[J]. Hepatology, 2014, 60(6): 2017-2026.
|
| 25 |
Francoz C, Nadim MK, Durand F. Kidney biomarkers in cirrhosis[J]. J Hepatol, 2016, 65(4): 809-824.
|
| 26 |
O′Riordan A, Wong V, McQuillan R, et al. Acute renal disease, as defined by the RIFLE criteria, post-liver transplantation[J]. Am J Transplant, 2007, 7(1): 168-176.
|
| 27 |
Nadim MK, Genyk YS, Tokin C, et al. Impact of the etiology of acute kidney injury on outcomes following liver transplantation: acute tubular necrosis versus hepatorenal syndrome[J]. Liver Transpl, 2012, 18(5): 539-548.
|
| 28 |
Piano S, Rosi S, Maresio G, et al. Evaluation of the acute kidney injury network criteria in hospitalized patients with cirrhosis and ascites[J]. J Hepatol, 2013, 59(3): 482-489.
|
| 29 |
Durand F, Graupera I, Gines P, et al. Pathogenesis of hepatorenal syndrome: implications for therapy[J]. Am J Kidney Dis, 2016, 67(2): 318-328.
|
| 30 |
Trawale JM, Paradis V, Rautou PE, et al. The spectrum of renal lesions in patients with cirrhosis: a clinicopathological study[J]. Liver Int, 2010, 30(5): 725-732.
|
| 31 |
Hilmi IA, Damian D, Al-Khafaji A, et al. Acute kidney injury following orthotopic liver transplantation: incidence, risk factors, and effects on patient and graft outcomes[J]. Br J Anaesth, 2015, 114(6): 919-926.
|
| 32 |
Leithead JA, Tariciotti L, Gunson B, et al. Donation after cardiac death liver transplant recipients have an increased frequency of acute kidney injury[J]. Am J Transplant, 2012, 12(4): 965-975.
|
| 33 |
Goren O, Matot I. Update on perioperative acute kidney injury[J]. Curr Opin Crit Care, 2016, 22(4): 370-378.
|
| 34 |
Aggarwal S, Kang Y, Freeman JA, et al. Postreperfusion syndrome: hypotension after reperfusion of the transplanted liver[J]. J Crit Care, 1993, 8(3): 154-160.
|
| 35 |
De Haan JE, Hoorn EJ, de Geus HRH. Acute kidney injury after liver transplantation：Recent insights and future perspectives[J]. Best Pract Res Clin Gastroenterol, 2017, 31(2): 161-169.
|
| 36 |
Karkouti K. Transfusion and risk of acute kidney injury in cardiac surgery[J]. Br J Anaesth, 2012, 109(Suppl 1): i29-i38.
|
| 37 |
Chow FS, Piekoszewski W, Jusko WJ. Effect of hematocrit and albumin concentration on hepatic clearance of tacrolimus (FK506) during rabbit liver perfusion[J]. Drug Metab Dispos, 1997, 25(5): 610-616.
|
| 38 |
Yoo S, Lee HJ, Lee H, et al. Association between perioperative hyperglycemia or glucose variability and postoperative acute kidney injury after liver transplantation: a retrospective observational study[J]. Anesth Analg, 2017, 124(1): 35-41.
|
| 39 |
Wadei HM, Lee DD, Croome KP, et al. Early allograft dysfunction after liver transplantation is associated with short-and long-term kidney function impairment[J]. Am J Transplant, 2016, 16(3): 850-859.
|
| 40 |
Laing RW, Scalera I, Isaac J, et al. Liver transplantation using grafts from donors after circulatory death: A propensity-matched study from a single centre[J]. Am J Transplant, 2016, 16(6): 1795-1804.
|
| 41 |
Elia C, Graupera I, Barreto R, et al. Severe acute kidney injury associated with nonsteroidal anti-inflammatory drugs in cirrhosis: a case-control study[J]. J Hepatol, 2015, 63(3): 593-600.
|
| 42 |
Angeli P, Gines P, Wong F, et al. Diagnosis and management of acute kidney injury in patients with cirrhosis: revised consensus recommendations of the International Club of Ascites[J]. J Hepatol, 2015, 62(4): 968-974.
|
| 43 |
Rodriguez E, Henrique Pereira G, Sola E, et al. Treatment of type 2 hepatorenal syndrome in patients awaiting transplantation: effects on kidney function and transplantation outcomes[J]. Liver Int, 2015, 21(11): 1347-1354.
|
| 44 |
Fernandez J, Navasa M, Planas R, et al. Primary prophylaxis of spontaneous bacterial peritonitis delays hepatorenal syndrome and improves survival in cirrhosis[J]. Gastroenterology, 2007, 133(3): 818-824.
|
| 45 |
European Association for the Study of the Liver. EASL clinical practice guidelines on the management of ascites, spontaneous bacterial peritonitis, and hepatorenal syndrome in cirrhosis[J]. J Hepatol, 2010, 53(3): 397-417.
|
| 46 |
Serste T, Francoz C, Durand F, et al. Beta-blockers cause paracentesis-induced circulatory dysfunction in patients with cirrhosis and refractory ascites: a cross-over study[J]. J Hepatol, 2011, 55(4): 794-799.
|
| 47 |
Leithead JA, Rajoriya N, Tehami N, et al. Non-selective beta-blockers are associated with improved survival in patients with ascites listed for liver transplantation[J]. Gut, 2015, 64(7): 1111-1119.
|
| 48 |
Nadim MK, Durand F, Kellum JA, et al. Management of the critically ill patient with cirrhosis: a multidisciplinary perspective[J]. J Hepatol, 2016, 64(3): 717-735.
|
| 49 |
Wierstra BT, Kadri S, Alomar S, et al. The impact of" early" versus " late" initiation of renal replacement therapy in critical care patients with acute kidney injury: a systematic review and evidence synthesis[J]. Crit Care, 2016, 20(1): 122.
|
| 50 |
Zarbock A, Kellum JA, Schmidt C, et al. Effect of early vs delayed initiation of renal replacement therapy on mortality in critically ill patients with acute kidney injury: the ELAIN randomized clinical trial[J]. JAMA, 2016, 315(20): 2190-2199.
|
| 51 |
Paugam-Burtz C, Kavafyan J, Merckx P, et al. Postreperfusion syndrome during liver transplantation for cirrhosis: outcome and predictors[J]. Liver Transpl, 2009, 15(5): 522-529.
|
| 52 |
Schmitz V, Schoening W, Jelkmann I, et al. Different cava reconstruction techniques in liver transplantation: piggyback versus cava resection[J]. Hepatobiliary Pancreat Dis Int, 2014, 13(3): 242-249.
|
| 53 |
Pratschke S, Meimarakis G, Bruns CJ, et al. Temporary intraoperative porto-caval shunt：useless or beneficial in piggy back liver transplantation？[J]. Transplant Int, 2013, 26(1): 90-98.
|
| 54 |
Salom MG, Ramirez P, Carbonell LF, et al. Protective effect of N-acetyl-L-cysteine on the renal failure induced by inferior vena cava occlusion[J]. Transplantation, 1998, 65(10): 1315-1321.
|
| 55 |
Durand F. Hot-topic debate on kidney function: renal-sparing approaches are beneficial[J]. Liver Transpl, 2011, 17(Suppl 3): S43-S49.
|
| 56 |
Kong Y, Wang D, Shang Y, et al. Calcineurin-inhibitor minimization in liver transplant patients with calcineurin-inhibitor-related renal dysfunction: a meta-analysis[J]. PLoS One, 2011, 6(9): e24387.
|
| 57 |
Goralczyk AD, Bari N, Abu-Ajaj W, et al. Calcineurin inhibitor sparing with mycophenolate mofetil in liver transplantion: a systematic review of randomized controlled trials[J]. Am J Transplant, 2012, 12(10): 2601-2607.
|
| 58 |
Teperman L, Moonka D, Sebastian A, et al. Calcineurin inhibitor-free mycophenolate mofetil/sirolimus maintenance in liver transplantation: the randomized spare-the-nephron trial[J]. Liver Transpl, 2013, 19(7): 675-689.
|
| 59 |
Fischer L, Klempnauer J, Beckebaum S, et al. A randomized, controlled study to assess the conversion from calcineurin-inhibitors to everolimus after liver transplantation-PROTECT[J]. Am J Transplant, 2012, 12(7): 1855-1865.
|
| 60 |
Klintmalm GB, Feng S, Lake JR, et al. Belatacept-based immunosuppression in de novo liver transplant recipients: 1-year experience from a phase Ⅱ randomized study[J]. Am J Transplant, 2014, 14(8): 1817-1827.
|
| 61 |
Yoshida EM, Marotta PJ, Greig PD, et al. Evaluation of renal function in liver transplant recipients receiving daclizumab (Zenapax), mycophenolate mofetil, and a delayed, low-dose tacrolimus regimen vs. a standard-dose tacrolimus and mycophenolate mofetil regimen: a multicenter randomized clinical trial[J]. Liver Transpl, 2005, 11(9): 1064-1072.
|
| 62 |
Abdelmalek MF, Humar A, Stickel F, et al. Sirolimus conversion regimen versus continued calcineurin inhibitors in liver allograft recipients: a randomized trial[J]. Am J Transplant, 2012, 12(3): 694-705.
|
| 63 |
Lin M, Mittal S, Sahebjam F, et al. Everolimus with early withdrawal or reduced-dose calcineurin inhibitors improves renal function in liver transplant recipients: a systematic review and meta-analysis[J]. Clin Transplant, 2017, 31(2): e12872.
|
| 64 |
Davis CL, Feng S, Sung R, et al. Simultaneous liver-kidney transplantation: evaluation to decision making[J]. Am J Transplant, 2007, 7(7): 1702-1709.
|
| 65 |
Simpson N, Cho YW, Cicciarelli JC, et al. Comparison of renal allograft outcomes in combined liver-kidney transplantation versus subsequent kidney transplantation in liver transplant recipients: analysis of UNOS database[J]. Transplantation, 2006, 82(10): 1298-1303.
|